887 studies found for:    "Hepatitis C, Chronic"
Show Display Options
Rank Status Study
21 Unknown  HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Oral HDV-Interferon + ribavarin;   Drug: Injectable HDV-Interferon + ribavarin
22 Completed Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Peginterferon alfa-2a
23 Recruiting Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C Infection
Intervention:
24 Completed An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated-Interferon-alfa-2a
25 Completed Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Amantadine
26 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
27 Completed Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha2a;   Drug: ribavirin
28 Terminated Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Procedure: Blood sampling of peripheral blood mononuclear cells;   Procedure: Blood draw, 20ml peripheral blood mononuclear cells
29 Unknown  Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition: Chronic Hepatitis C
Intervention: Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
30 Completed A Study of Combination Treatment With PEGASYS (Peginterferon Alfa-2a (40KD) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: ribavirin [Copegus]
31 Recruiting Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
32 Completed Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection
Condition: Chronic Hepatitis C
Intervention: Drug: KRN7000
33 Completed Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Nitazoxanide
34 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
35 Active, not recruiting Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers
Condition: Chronic Hepatitis C
Intervention:
36 Terminated Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Procedure: therapeutic drug monitoring of ribavirin and dose adaptation
37 Completed Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha and plus ribavirin;   Drug: pegylated interferon alpha and plus ribavirin
38 Completed Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Obesity
Intervention:
39 Completed Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices
Conditions: Chronic Hepatitis C;   Hepatic Fibrosis;   Cirrhosis
Intervention:
40 Completed
Has Results
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ursodeoxycholic acid 150mg / day;   Drug: Ursodeoxycholic acid 600mg / day;   Drug: Ursodeoxycholic acid 900mg / day

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years